Literature DB >> 8603073

Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.

J R Gnarra1, D R Duan, Y Weng, J S Humphrey, D Y Chen, S Lee, A Pause, C F Dudley, F Latif, I Kuzmin, L Schmidt, F M Duh, T Stackhouse, F Chen, T Kishida, M H Wei, M I Lerman, B Zbar, R D Klausner, W M Linehan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8603073     DOI： 10.1016/0304-419x(95)00012-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  45 in total

1.  Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein.

Authors:  A Pause; B Peterson; G Schaffar; R Stearman; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  New antiangiogenic agents for renal cell carcinoma: interferon alfa and thalidomide.

Authors:  Ronald M Bukowski
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

3.  Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice.

Authors:  J R Gnarra; J M Ward; F D Porter; J R Wagner; D E Devor; A Grinberg; M R Emmert-Buck; H Westphal; R D Klausner; W M Linehan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 4.  Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.

Authors:  Apurva A Desai; Walter M Stadler
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

5.  The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells.

Authors:  S Koochekpour; M Jeffers; P H Wang; C Gong; G A Taylor; L M Roessler; R Stearman; J R Vasselli; W G Stetler-Stevenson; W G Kaelin; W M Linehan; R D Klausner; J R Gnarra; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 6.  The von Hippel-Lindau gene: turning discovery into therapy.

Authors:  Peter E Clark; Michael S Cookson
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

7.  Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.

Authors:  S Lee; M Neumann; R Stearman; R Stauber; A Pause; G N Pavlakis; R D Klausner
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

8.  The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families.

Authors:  T Kamura; S Sato; D Haque; L Liu; W G Kaelin; R C Conaway; J W Conaway
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

9.  Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells.

Authors:  M Gorospe; J M Egan; B Zbar; M Lerman; L Geil; I Kuzmin; N J Holbrook
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

10.  Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation.

Authors:  Cyntia Curcio-Morelli; Ann Marie Zavacki; Marcelo Christofollete; Balazs Gereben; Beatriz C G de Freitas; John W Harney; Zaibo Li; Guan Wu; Antonio C Bianco
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.